A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer
Condition(s):Breast NeoplasmsLast Updated:November 27, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Breast NeoplasmsLast Updated:November 27, 2019Completed
Condition(s):Refractory or Recurrent Solid Tumors; Rhabdomyosarcoma; Non-Rhabdomyosarcoma Soft Tissue Sarcoma; Ewing SarcomaLast Updated:June 28, 2022Completed
Condition(s):Triple Negative Breast CancerLast Updated:August 11, 2020Not yet recruiting
Condition(s):Breast CancerLast Updated:November 15, 2018Completed
Condition(s):Pediatrics; Solid TumorsLast Updated:January 15, 2019Completed
Condition(s):Metastatic Urothelial Cell CancerLast Updated:July 1, 2022Terminated
Condition(s):TumorLast Updated:March 15, 2017Completed
Condition(s):Breast Cancer; Advanced Breast Cancer; Metastatic Breast CancerLast Updated:February 21, 2024Recruiting
Condition(s):Metastatic Breast CancerLast Updated:July 13, 2020Terminated
Condition(s):HER2-positive Breast CancerLast Updated:July 14, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.